Next, 12 weeks after intravenously injecting HFD-fed ATF3−/− mice with AAV8-ATF3, body weight, serum TG levels, glucose intolerance, and insulin resistance were lower than in ATF3−/− mice injected with AAV8-GFP (Fig. 4a–d). Here, ATF3 is linked to Insulin resistance.